RCM
TDAC

Radcliffe Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Radcliffe Capital Management’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.35M Hold
505,514
– – 0.4% 87
2025
Q4 		$5.3M Buy
505,514
+1,209
+0.2% +$12.6K 0.29% 90
2025
Q3 		$5.22M Buy
504,305
+329,001
+188% +$3.4M 0.32% 62
2025
Q2 		$1.8M Buy
+175,304
New +$1.78M 0.14% 86

Other funds holding TDAC

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Radcliffe Capital Management's TDAC Position: Q1 2026 in Review

Radcliffe Capital Management held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 505,514 shares worth $5.35M. The position accounts for 0.4% of the portfolio, ranked #87.

Radcliffe Capital Management first reported a position in TDAC in Q2 2025 and has held it in 4 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Radcliffe Capital Management held 505,514 shares of Translational Development Acquisition Corp worth $5.35M as of Q1 2026.
  • Radcliffe Capital Management left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.4% of Radcliffe Capital Management's portfolio in Q1 2026, its #87 holding.
  • Radcliffe Capital Management first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Radcliffe Capital Management's 13F filing for Q1 2026, filed 15 May 2026.